Niroshana Anandasabapathy, M.D., Ph.D.
Dermatology
Dermatology
Niroshana Anandasabapathy, M.D., Ph.D.
Providing world-class care with
Specialties:
Adult Dermatology
Not Accepting New Patients
Locations and Appointments
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
*Indicates this doctor is no longer accepting new patients with this insurance plan.
- HMO
- Medicare
- PPO
- EPO/POS
- CHP
- Blue Access
- Blue Connection
- EPO
- HMO
- Mediblue (Senior)
- PPO
- CBP
- *Medicaid
- *Medicare
- Freedom
- Liberty
- *Medicare Advantage
- Metro/Core/Charter
- *Community Plan
- *Medicare
- *HMO
- *Medicare
About Niroshana Anandasabapathy, M.D., Ph.D.
Board Certifications
American Board of Dermatology
°ÅÀÖÊÓƵ Expertise
Melanoma
Melanoma Syndrome
Complex Medical Dermatology
Screening Exam For Skin Cancer
°ÅÀÖÊÓƵ Research
Dermatologic Oncology
Skin Check
Mole Mapping
Rapidly Changing Skin Growth
Skin Lesions
Languages
English
Research
Education
-
M.S.The Rockefeller University2012
-
M.D.Stanford University School of Medicine2005
-
Ph.D.Stanford University2004
-
B.A., B.S.Stanford University1997
Appointments
-
Associate Attending DermatologistNewYork-Presbyterian Hospital
-
Associate Professor of DermatologyWeill Cornell Medical College, Cornell University
-
Associate Professor of Dermatology in Microbiology and ImmunologyWeill Cornell Medical College, Cornell University
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, °ÅÀÖÊÓƵ physicians and scientists are sought after by many organizations to consult and educate. °ÅÀÖÊÓƵ and its faculty make this information available to the public, thus creating a transparent environment.
Consultant:
Genmab, Inc.
Janssen Pharmaceutical Company
Viela Bio
Advisory/Scientific Board Member:
Shennon Biotechnologies
Speaker/Lecturer:
Bristol-Myers Squibb Company
Ownership:
Shennon Biotechnologies
Other Interest:
Lytix Biopharma AS
Verrica Pharmaceuticals Inc.